Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients.
about
Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usageNew directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunityPosttransplant lymphoproliferative disease after pediatric solid organ transplantationComprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppressionLong-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.Impact of maintenance immunosuppressive regimens--balance between graft protective suppression of immune functions and a near physiological immune response.Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study.Risk factors for impaired CD4+ T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantationCumulative Doses of T-Cell Depleting Antibody and Cancer Risk after Kidney TransplantationManagement and prevention of post-transplant malignancies in kidney transplant recipientsCytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients.Can mTOR inhibitors reduce the risk of late kidney allograft failure?Treatment of autoimmune disease with rabbit anti-T lymphocyte globulin: clinical efficacy and potential mechanisms of action.Viral infection after renal transplantation: surveillance and management.Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients.The psychological management of facial transplantation.Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti-IL2 Receptor Monoclonal Antibodies?Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.The role of Thymoglobulin induction in kidney transplantation: an update.Steroid withdrawal in renal transplantation.A review on comparing two commonly used rabbit anti-thymocyte globulins as induction therapy in solid organ transplantation.Malignancies after pediatric kidney transplantation: more than PTLD?Role for immune monitoring to tailor induction prophylaxis in pediatric heart recipients.Time trends in risk and risk determinants of non-Hodgkin lymphoma in solid organ transplant recipients.A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review.Anti-thymocyte globulins in kidney transplantation: focus on current indications and long-term immunological side effects.Efficacy and safety of antibody induction therapy in the current era of kidney transplantation.Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.Relapsing EBV encephalitis in a renal transplant recipient.Extended experience with a steroid minimization immunosuppression protocol in pediatric renal transplant recipients.Altered balance between effector T cells and FOXP3+ HELIOS+ regulatory T cells after thymoglobulin induction in kidney transplant recipients.The incidence of non-melanoma skin cancer and post-transplant lympho-proliferative disorders in the Scottish cardiac transplant population and the provision of specialist dermatological follow-up.Reduced ATG-F dosage for induction in pediatric renal transplantation: a single-center experience.Cancer risk with alemtuzumab following kidney transplantation.Viral infection in renal transplant recipients.Risk factors associated with post–kidney transplant malignancies: an article from the Cancer-Kidney International Network.Epidemiology of Posttransplant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of Lymphomas
P2860
Q26784305-8333A9CC-5E36-4150-AE64-D80C078F1D6CQ26823090-967A6D97-BCF0-447D-97B6-7543E9E1FDB7Q26866013-0BB0CCDC-C564-442F-9DED-401CD771530EQ28545113-FD301DEF-64DE-4FB5-BD89-1653B73F630DQ30987986-A203EA29-4EA6-416F-BB2D-4BCB0603D39AQ33845320-6612EF9D-2603-4110-9FC5-FFF8DC83D5E4Q34027642-DA68B5E0-6692-4317-B32F-094EE1CC6DA3Q34805780-EDE6DD9C-DBBD-4BB7-9145-48C9D033BC89Q35837585-44E26445-12C3-4713-A8FF-987FFDB43EAAQ36088854-FF04D493-5F1B-48E3-81F3-B767DEEF1704Q36728782-54944CC7-3C20-4A55-8369-06B39E333A51Q36884566-2F15BD11-EEC8-48F7-B4BD-CBE91760EF7FQ36958333-1CB9817F-9D28-45EE-BB6A-2539A7977299Q37097708-EFD1E889-2EE4-4BA5-A608-506608F32910Q37211151-D97A74BD-6968-4A44-A8E5-CD6E348A91B1Q37546101-E294A69A-2010-4748-B1BF-B1C0AA2661E1Q37561282-C630B1BF-D495-4953-84E4-5E32C55C05A8Q37726624-3A728A27-50DE-4F80-ACB8-B83968410F3EQ38051718-F969E844-F97A-4F80-8C44-C8CA05C3E15CQ38071546-AF9819E6-DB5B-4807-B71F-042E7B52BBF5Q38123228-C5629FEB-80C8-4E4C-8287-69456F57C1F5Q38141838-C9F6AE72-480F-48A4-BF8B-02F96F95CE93Q38166794-B59CE85A-9921-41C7-8AD7-365C0B335438Q38437273-D0E948D4-F8FF-498E-9E5A-110D7EC5B5EFQ38619244-6C98E264-6BDB-4030-BC5A-2F1B93AFD9ECQ38933152-9601D8B2-6CE1-4A0B-BD45-F704BFC706A9Q38995172-CCB79DB7-F5D2-420A-8C29-28690F217EAAQ39757976-06DF3494-8A48-4C4D-8EBE-408282C0C457Q41189728-EDAAA197-2034-4D7E-A985-B37764DF8DD4Q41918609-52133B67-75B1-4B24-8B33-03BB7475AC61Q43256698-DF15CF85-CE55-495D-94B2-77A2529F7B47Q46987447-B566AFA2-1E44-4D71-B345-F872ECB0F047Q50090795-9EBBB261-2047-48B6-BC43-A8F75F1E971CQ50732348-86E594D4-411D-4A56-B5F6-DBF05A541C2AQ50866852-0522A0CB-1E94-4F04-9DA7-BE44E7D6F340Q51594265-B51D027F-BECA-4366-8C21-AD0FCCF88012Q55266341-168E2F08-781F-47D0-9C45-367A3346EA5AQ56908048-73A922DE-2D0D-483F-BA13-20F3E4133D8B
P2860
Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Disassociation between risk of ...... n renal transplant recipients.
@ast
Disassociation between risk of ...... n renal transplant recipients.
@en
type
label
Disassociation between risk of ...... n renal transplant recipients.
@ast
Disassociation between risk of ...... n renal transplant recipients.
@en
prefLabel
Disassociation between risk of ...... n renal transplant recipients.
@ast
Disassociation between risk of ...... n renal transplant recipients.
@en
P2093
P1433
P1476
Disassociation between risk of ...... n renal transplant recipients.
@en
P2093
Bernd Döhler
Cord Naujokat
Peter Terness
Volker Daniel
P304
P356
10.1097/01.TP.0000219817.18049.36
P577
2006-05-01T00:00:00Z